A M Verweij-Van Vught - JoVE Visualize

Showing results (21-30 of 33) with videos related to

Pageof 4

Sort By:

Journal of Medical Microbiology|May 1, 1983

K antigens of Escherichia coli and virulence in urinary-tract infection: studies in a mouse modelA M Verweij-van Vught, J F van den Bosch, F Namavar, et al.

Immunology Letters|July 1, 1992

Murine ascitic fluids contain varying amounts of an inhibitor that interferes with complement-mediated effector functions of monoclonal antibodiesB J Appelmelk, A M Verweij-Van Vught, J J Maaskant, et al.

Infection and Immunity|September 1, 1991

Human immune response to an iron-repressible outer membrane protein of Bacteroides fragilisB R Otto, W R Verweij, M Sparrius, et al.

Agents and Actions|December 1, 1987

Influence of rosmarinic acid on opsonization and intracellular killing of Escherichia coli and Staphylococcus aureus by porcine and human polymorphonuclear leucocytesA M Verweij-van Vught, B J Appelmelk, A B Groeneveld, et al.

Microbial Pathogenesis|October 1, 1988

Comparison of monoclonal antibodies to the deeper core region of gram-negative lipopolysaccharide by means of polymyxin B inhibition studiesB J Appelmelk, A M Verweij-van Vught, J J Maaskant, et al.

Diabetes Care|January 1, 1990

Preservatives in insulin preparations impair leukocyte function. In vitro studyI van Faassen, A M Verweij-van Vught, M Z Lomecky-Janousek, et al.

Journal of Medical Microbiology|July 1, 1989

Epidemiology of the Bacteroides fragilis group in the colonic flora in 10 patients with colonic cancerF Namavar, E B Theunissen, A M Verweij-Van Vught, et al.

European Journal of Clinical Microbiology|June 1, 1986

Effect of Bacteroides fragilis grown in the presence of clindamycin, metronidazole and fusidic acid on opsonization and killing of Escherichia coliF Namavar, J A Kaan, A M Verweij-van Vught, et al.

Microbial Pathogenesis|October 1, 1988

Prevention of lethal endotoxemia in actinomycin D-sensitized mice by incubation of Salmonella minnesota R595 lipopolysaccharide with monoclonal antibodies to R595B J Appelmelk, A M Verweij-van Vught, H Brade, et al.

Journal of General Microbiology|November 1, 1993

Antigenic and immunogenic differences in lipopolysaccharides of Escherichia coli J5 vaccine strains of different originsB J Appelmelk, J J Maaskant, A M Verweij-van Vught, et al.

Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:

Pageof 4

Journal of Medical Microbiology|May 1, 1983

K antigens of Escherichia coli and virulence in urinary-tract infection: studies in a mouse modelA M Verweij-van Vught, J F van den Bosch, F Namavar, et al.

Immunology Letters|July 1, 1992

Murine ascitic fluids contain varying amounts of an inhibitor that interferes with complement-mediated effector functions of monoclonal antibodiesB J Appelmelk, A M Verweij-Van Vught, J J Maaskant, et al.

Infection and Immunity|September 1, 1991

Human immune response to an iron-repressible outer membrane protein of Bacteroides fragilisB R Otto, W R Verweij, M Sparrius, et al.

Agents and Actions|December 1, 1987

Influence of rosmarinic acid on opsonization and intracellular killing of Escherichia coli and Staphylococcus aureus by porcine and human polymorphonuclear leucocytesA M Verweij-van Vught, B J Appelmelk, A B Groeneveld, et al.

Microbial Pathogenesis|October 1, 1988

Comparison of monoclonal antibodies to the deeper core region of gram-negative lipopolysaccharide by means of polymyxin B inhibition studiesB J Appelmelk, A M Verweij-van Vught, J J Maaskant, et al.

Diabetes Care|January 1, 1990

Preservatives in insulin preparations impair leukocyte function. In vitro studyI van Faassen, A M Verweij-van Vught, M Z Lomecky-Janousek, et al.

Journal of Medical Microbiology|July 1, 1989

Epidemiology of the Bacteroides fragilis group in the colonic flora in 10 patients with colonic cancerF Namavar, E B Theunissen, A M Verweij-Van Vught, et al.

European Journal of Clinical Microbiology|June 1, 1986

Effect of Bacteroides fragilis grown in the presence of clindamycin, metronidazole and fusidic acid on opsonization and killing of Escherichia coliF Namavar, J A Kaan, A M Verweij-van Vught, et al.

Microbial Pathogenesis|October 1, 1988

Prevention of lethal endotoxemia in actinomycin D-sensitized mice by incubation of Salmonella minnesota R595 lipopolysaccharide with monoclonal antibodies to R595B J Appelmelk, A M Verweij-van Vught, H Brade, et al.

Journal of General Microbiology|November 1, 1993

Antigenic and immunogenic differences in lipopolysaccharides of Escherichia coli J5 vaccine strains of different originsB J Appelmelk, J J Maaskant, A M Verweij-van Vught, et al.

Pageof 4